Navigating the landscape of end-of-life care and access to medications like this drug in New South Wales, NSW, requires a careful comprehension of the detailed legal structure. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by clinical profession